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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYAs the quintessential reprogramming model, OCT3/4, SOX2, KLF4, and c-MYC re-wire somatic cells to achieve induced pluripotency.
Yet, subtle differences inmethodology confound comparative studies of reprogrammingmechanisms. Employing transposons, we system-
atically assessed cellular andmolecular hallmarks ofmouse somatic cell reprogramming by various polycistronic cassettes. Reprogramming
responses varied in the extent of initiation and stabilization of transgene-independent pluripotency. Notably, the cassettes employed one
of two KLF4 variants, differing only by nine N-terminal amino acids, which generated dissimilar protein stoichiometry. Extending the
shorter variant by nine N-terminal amino acids or augmenting stoichiometry by KLF4 supplementation rescued both protein levels and
phenotypic disparities, implicating a threshold in determining reprogramming outcomes. Strikingly, global gene expression patterns
elicited by published polycistronic cassettes diverged according to each KLF4 variant. Our data expose a Klf4 reference cDNA variation
that alters polycistronic factor stoichiometry, predicts reprogramming hallmarks, and guides comparison of compatible public data sets.INTRODUCTION
Cellular identity can be guided by ectopic expression of
master regulators (Graf, 2011). Deriving induced pluripo-
tent stem cells (iPSCs) through the activities of OCT3/4,
SOX2, KLF4, and c-MYC (Takahashi and Yamanaka,
2006) provides a potent model in which to study the
role of transcription factor coordination in driving so-
matic cells toward pluripotency. Early mechanistic
studies using mouse embryonic fibroblasts (MEFs) were
conducted through de novo introduction of viral vectors,
each expressing an individual (monocistronic) reprog-
ramming factor (Brambrink et al., 2008; Stadtfeld et al.,
2008a), where modulation of factor levels by viral
titration led to altered reprogramming characteristics
(Yamaguchi et al., 2011). Monocistronic reprogramming
allows for variation in copy number and integration
site, and as a result, stoichiometry is inconsistent on a
cell-to-cell level. Therefore, this method was succeeded
by the development of polycistronic factor cassettes
that can produce multiple proteins from one single
transcript (Kaji et al., 2009; Sommer et al., 2009).
Although such fixed polycistronic stoichiometry revealed
the importance of relative factor ratios in determining
the quality of reprogramming (Carey et al., 2011), the
principles that establish optimal stoichiometry remain
undefined.StemStudies of the mechanisms that underlie somatic
cell reprogramming have revealed multi-step processes
involving proliferation and cell-cell adhesion, along with
molecular changes such as downregulation of lineage-spe-
cific genes and eventual upregulation of pluripotency
markers (Plath and Lowry, 2011). Cell-surface markers
were associated with reprogramming stages such as emer-
gence of the embryonic stem cell (ESC) marker SSEA-1
(stage-specific embryonic antigen 1) (Polo et al., 2012;
Stadtfeld et al., 2008a). Secondary reprogramming systems
(Woltjen et al., 2009) helped define initiation, maturation,
and stabilization as key stages in reprogramming toward
pluripotency (David and Polo, 2014). Proliferation, colony
formation, and a mesenchymal-to-epithelial transition
(MET) define the initiation phase (Samavarchi-Tehrani
et al., 2010), while stabilization is characterized by trans-
gene independence and activation of pluripotency re-
porters such as Nanog and Dppa4 (Golipour et al., 2012).
Thus, changes in global gene expression and epigenetics
were associated with the progression of reprogramming
through these stages (Theunissen and Jaenisch, 2014).
However, discrepancies in reprogramming platforms
influence reprogramming hallmarks, the severity of MET
responses, lineage-specific gene repression and ectopic
activation, the timing of cell-surface marker presentation,
and the frequency of partial and complete reprogramming
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et al., 2013; Polo et al., 2012; Samavarchi-Tehrani et al.,
2010; Wernig et al., 2008).
In order to clarify such method-dependent reprogram-
ming hallmarks, we applied standard assays to compare
polycistronic cassettes (constructed in-house or obtained
from public resources) in a drug-inducible piggyBac (PB)
transposon reprogramming system. The induced expres-
sion of various polycistronic cassettes in mouse fibroblasts
evoked phenotypic and gene expression changes that we
divided into two basic behavioral classes. An examination
of individual factor sequences across the panel of polycis-
tronic constructs revealed a re-occurring discrepancy in
the Klf4 cDNA defining two coding region length variants.
Increased length at the KLF4 N terminus was associated
with higher protein levels and thus altered relative factor
stoichiometry, ultimately impacting both the initiation
and stabilization phases of iPSC derivation. Here, we report
the consequences of KLF4 N-terminal variation in mono-
and polycistronic reprogramming experiments, and apply
these findings to recognize and reconcile differences in
reprogramming characteristics implied hitherto.RESULTS
A Transposon System for Collating Polycistronic
Reprogramming Cassettes
Reprogramming studies inmouse havemade use of unique
polycistronic factor arrangements and delivery vectors. For
uniform evaluation of factor-order effects, we employedFigure 1. KLF4 Isoforms Underlie Phenotypic Differences in Repr
(A) Diagram of the PB reprogramming system and analysis steps. Th
polycistronic reprogramming cassettes (Poly) into ROSA-rtTA; Nanog-G
and harvested on d8 for FACS and passage for late-stage analysis (d18)
Full reprogramming and transgene independence is assessed by dox
periods for the mCherry and GFP reporters during iPSC derivation are sh
(left) and 50 (right) inverted terminal repeats. tetO, dox-responsive p
signal.
(B) AP staining on d10 of OSKM and OKMS reprogramming cultures. S
(C) Day 18 fluorescence microscopy of entire wells (composite 103 10
GFP+ (left). Scale bars, 4,000 mm (full well) and 1,000 mm (inset). FA
SSEA-1+ populations (right).
(D) Polycistronic cassette structure and sequence of the 2A-Klf4 N-t
Klf4 GenBank mRNA sequences (U20344.1 and U70662.1), indicatin
translations. The N-terminal 9aa of U20344.1 were introduced into O
(E and F) The OK+9MS construct was evaluated according to the as
representative of the results from at least three independent experim
(G and H) Time-course analysis of mCherry+ cell expansion (G) and S
cultured for the indicated number of days before (2, 4, 6, 8) and a
experiments.
(I and J) Time-course analysis of mCherry silencing (left) and Nanog-
days after day 8 passage (10, 14, and 18). Means ± SE for three inde
See also Figure S1.
Stema fundamental reprogramming scheme based on factor
transposition in MEFs (Woltjen et al., 2009). The PB trans-
poson vector (PB-TAC) employs doxycycline (dox)-respon-
sive reprogramming cassette expression co-incidentally
with a mCherry reporter (Figure 1A). ROSA-rtTA; Nanog-
GFP MEFs combine the m2-rtTA transactivator (Ohnishi
et al., 2014) with a Nanog-GFP reporter (Okita et al.,
2007). Thus, dox-responsive, PB-TAC-transgenic cells can
be monitored throughout reprogramming initiation and
maturation (day 2 [d2]–14) bymCherry fluorescence, while
stabilization of pluripotency (d14–18) is indicated by acti-
vation ofNanog-GFP.Gain of factor independence through
autonomous transgene silencing despite continued dox
treatment is an established hallmark of the stabilization
phase (Golipour et al., 2012), signaled here by a decrease
in mCherry expression. For all polycistronic reprogram-
ming cassettes tested, we routinely passaged populations
on d8 and d18 using equal cell numbers without fraction-
ation for extended culture and fluorescence-activated cell
sorting (FACS) analysis. Dox-independent maintenance
of iPSCs was verified by culture until d24, after which
pluripotency was assayed by gene expression array and
chimera contribution.
Initially, we used an alkaline phosphatase-positive (AP+)
colony formation assay on d10 to compare various polycis-
tronic cassettes with two previously published versions:
OSKM (Carey et al., 2009) and MKOS (Kaji et al., 2009).
Across the range of vectors tested, OKMS, constructed
through the combination of OSKM and pCX-OKS-2A
(Okita et al., 2008), displayed a reprogramming phenotypeogramming
e PB-TAC transposon delivers inducible, reporter-linked (mCherry),
FP MEFs (d-1). Cultures are induced with dox (d0, dox; filled arrows)
. For AP staining, cultures are maintained without passage until d10.
withdrawal from d18 to d24 (open arrows). Predicted expression
own with red and green gradated bars. Blue polygons represent PB 30
romoter; IRES, internal ribosome entry signal; pA, polyadenylation
cale bar, 4,000 mm.
fields) or selected insets (33 3 subfields) for mCherry+ and Nanog-
CS analysis of mCherry and Nanog-GFP expression in d18 Total and
erminal cleavage junctions. Cloned cDNA is compared with murine
g the position of the predicted initiation codons and amino acid
KMS (Klf4S) to produce OK
+9MS (Klf4L).
says outlined in (A)–(C). The results in (B), (C), (E), and (F) are
ents (summarized in Figures S1A and S1B).
SEA-1+ fractions (H) from OSKM, OKMS, and OK+9MS transfections
fter (10, 14, and 18) passage. Means ± SE for three independent
GFP activation (right) in SSEA-1+ cells on the indicated number of
pendent experiments.
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contradictory to OSKM and MKOS (Figure 1B and data not
shown). Despite similar transfection efficiencies (3%–5%
mCherry+ cells at d2 for both OSKM and OKMS), OKMS-
induced AP+ colonies were clearly more abundant by d10,
indicating that OKMS initiated somatic reprogramming
more robustly than OSKM (Figures 1B and S1A).
To evaluate iPSC stabilization, we assayed activation of
the Nanog-GFP pluripotency reporter and silencing of fac-
tor-linked mCherry after d8 passage of OSKM and OKMS
reprogramming cultures. Whole-well microscopic evalua-
tion revealed that most OKMS-induced colonies were
unable to activate Nanog-GFP by d18 (Figure 1C, left),
whereas mCherry expression remained high. In contrast,
OSKM cultures showed a majority of GFP+ colonies with
silenced mCherry. FACS on d18 confirmed the proportions
of reporter-positive cells (Figure 1C, right). Both the Total
GFP+ and SSEA-1+ GFP+ fractions on d18 were consistently
higher for OSKM reprogramming (mean 15.6% and 39.5%,
respectively, versus 5.4% and 9.9% for OKMS; Figure S1B).
Conversely, overrepresentation of Total mCherry+ and
SSEA-1+ mCherry+ populations was characteristic of OKMS
(mean 53.1% and 58.8%, respectively, versus 21.0% and
27.0% for OSKM; Figure S1B). GFP+ cells emerged only
in the SSEA-1+ fraction (data not shown), and only in
mCherrylow or mCherry cells, such that double-positive
GFP+ mCherry+ cells were not observed under either con-
dition (Figure 1C, right). Reporter ratios remained mostly
unchanged after d18 passage and an additional 6 days of
culture in dox (d24; Figure S1C, left). Failure to activate
Nanog-GFP was not associated exclusively with transgene
interference, as dox withdrawal led to a complete loss of
mCherry, but no increase in GFP for either the OSKM
or OKMS populations (Figures S1C and S1D). For both
vectors, dox-independent, Nanog-GFP+ iPSC clones contri-
buted to chimera formation and clustered with ESCs in
microarray transcriptome analyses, validating pluripo-
tency (Figures S1E–S1G). These data suggest that OSKM
more readily achieves stable reprogramming, whereas the
majority of OKMS-induced cells remain in a transgene-
dependent, partially reprogrammed state.
KLF4 Isoforms Underlie Phenotypic Differences in
Polycistronic Cassette Reprogramming
We next sought to expose key differences underlying
the distinct phenotypes observed for OSKM and OKMS,
and initially examined the reprogramming factors at the
DNA sequence level. Of particular interest, the 2A peptide
cleavage site preceding Klf4 in OSKM demarcated an
ATG initiation codon that included an additional nine
N-terminal amino acids (9aa) compared with that for
OKMS (Figure 1D). When we examined public databases,
we found that these two distinct Klf4 isoforms correspond
to open reading frames (ORFs) predicted from full-length730 Stem Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The AuthocDNA cloning (GenBank accession numbers U70662.1
and U20344.1) (Garrett-Sinha et al., 1996; Shields et al.,
1996), anticipating proteins of 474aa and 483aa (GenBank
accession numbers AAC52939.1 and AAC04892.1; hence-
forth referred to as KLF4S and KLF4L). To examine the
effects of KLF4S and KLF4L on reprogramming while ruling
out differences in factor order and 2A cleavage peptides,
we introduced the N-terminal 9aa noted in OSKM
(MRQPPGESD) directly into OKMS, producing OK+9MS
(where K+9 is equivalent to KLF4L).
MEFs transposed with OK+9MS displayed a complete
phenotypic switch. AP+ colony formation resembled that
of OSKM (Figures 1E and S1A). Whole-well imaging on
d18 strikingly revealed that OK+9MS colonies were primar-
ily GFP+ and there were few mCherry+ colonies (Figure 1F,
left). The Total and SSEA-1+ fractions on d18 were pre-
dominantly GFP+ with extensive mCherry silencing, mir-
roring OSKM reprogramming behavior (Figures 1F, right,
and S1B). Dox-independent, GFP+ OK+9MS clones were
chimera competent and shared a gene expression profile
with OSKM and OKMS iPSCs, and ESCs (Figures S1E–S1G).
Extended FACS analysis revealed the kinetics of
mCherry+ cell expansion throughout the early phase
(d2–8), equating OK+9MS with OSKM (Figure 1G). From
our d8 FACS data, we found that a large proportion of
OKMS mCherry+ cells were positive for SSEA-1. Therefore,
we traced SSEA-1 dynamics from d2 to d8 (mCherry+ frac-
tion; Figure 1H, left) and d10 to 18 post-passage (Total pop-
ulation; Figure 1H, right). Notably, only OKMS cultures
were distinguished by rapid and robust SSEA-1 activation
as early as d2 (29.4% versus 4.8% for OSKM, and 8.5% for
OK+9MS), which continued through early reprogramming.
For all constructs, SSEA-1+ cells remained mCherry+
through d8, at which point noNanog-GFP activation could
be detected. An examination of the increasing proportion
of SSEA-1+ cells over d10–18 (Figure 1H, right) showed
that activation of Nanog-GFP and coincident suppression
of mCherry by OK+9MS were more consistent with OSKM,
whereas for OKMS, both mCherry silencing and Nanog-
GFP activation were less frequent (Figures 1I and 1J). Over-
all, these data indicate that elongation of Klf4S to Klf4L
in OK+9MS subdues early reprogramming hallmarks but
positively regulates stabilization of pluripotency.
Monocistronic Expression of Klf4S or Klf4L Does
Not Differentially Influence Reprogramming
To determine whether the observed cassette-specific phe-
notypes were due to functional differences between
KLF4S and KLF4L, we performed a series of monocistronic
Klf4 expression experiments. We found that the transcrip-
tome profiles of d6 mCherry+ cells arising from PB-TAC-
Klf4S or -Klf4L MEF transfections were highly correlated
(R = 0.999; Figure S2A). Gene enrichment compared withrs
mock-transfected MEFs revealed a common set of 476
genes enriched for Gene Ontology (GO) terms associated
with extracellular matrix, skin development, and cell
adhesion (Figure S2B). Activation of a KLF4-responsive
Lefty1-luciferase reporter (Nakatake et al., 2006) was similar
irrespective of the KLF4 variant (Figure S2C), indicating
that the capacity for regulation of this ESC promoter was
unchanged. Moreover, both KLF4S and KLF4L could simi-
larly rescue leukemia inhibitory factor (LIF)-independent
culture of 1A2 Nanog-GFP reporter ESCs (data not shown).
Thus, independent expression of either Klf4 variant sup-
ported a preservation of functional capacity.
Considering the remarkable reprogramming pheno-
types observed with polycistronic cassettes, we next
addressed whether monocistronic expression of Klf4S or
Klf4L in combination with polycistronic Oct3/4, Sox2, and
c-Myc (OMS) had any detectable effect on iPSC derivation.
OMS alone did not foster expansion of mCherry+ cells,
which remained at a steady 6% through d18, nor did
it activate SSEA-1 or Nanog-GFP expression (data not
shown). Interestingly, expression of either Klf4 variant in
combination with OMS resulted in nearly indistinguish-
able reprogramming phenotypes using the assays outlined
in Figure 1 (see also Figures 2A, S2D, and S2E). These data
demonstrate that the phenotypes associated with KLF4S
and KLF4L arise mainly in the context of polycistronic
factor linkage.
KLF4 Levels Are Diminished in OKMS and Rescued
by N-Terminal Elongation
In order to rationalize the phenotypic differences observed
between polycistronic cassettes, we evaluated transgene
expression at the transcriptional and translational levels.
Quantification of polycistronic mRNA revealed similar
expression levels for OSKM and OKMS (Figure S2F). Strik-
ingly, western blotting on d2 revealed that dox-induced
KLF4 was expressed at distinctly higher levels in OSKM
compared with OKMS, whereas the levels of OCT3/4,
SOX2, and c-MYC were generally comparable (Figure 2B).
High KLF4 stoichiometry was also observed in MKOS,
which, like OSKM, encodes KLF4L (Figure S2G). Consistent
with the PB transposon experiments, MEFs from gene-
targeted Col1a1-OSKM (Ohnishi et al., 2014) and -OKMS
ESC chimeras faithfully reproduced cassette-specific pro-
tein levels (data not shown). Moreover, OK+9MS resulted
in a marked increase in KLF4 levels compared with
OKMS (Figure S2H). Surprisingly, N-terminal elongation
of KLF4S in OKMS with a hemagglutinin (HA) epitope
also rescued protein levels (OKN-HAMS; Figure S2H) and
even reprogramming phenotypes (Figure S2I), whereas
N-terminal HA extension of KLF4L in OK
+9MS did not
result in any additional phenotypic change. Concordant
with monocistronic phenotypes, transfection of PB-TAC-StemKlf4S or -Klf4L in MEFs produced comparable protein levels
on d2 (Figure S2J). These data indicate that the protein
sequence at the KLF4 N terminus plays a role in specifically
establishing polycistronic factor stoichiometry.
KLF4 Stoichiometry Regulates Reprogramming
To verify the reprogramming outcomes from adjusted
factor stoichiometry, we supplemented OKMS with mono-
cistronic factors in a PB-TAB transposon (Figure 2C). Sup-
plementation of OKMS with Klf4S or Klf4L (Figure S2J)
markedly reduced d10 AP+ colony numbers (Figures 2D
and 2G), reminiscent of the reduced colony formation
efficiencies observed when OSKM or OK+9MS was em-
ployed. Sox2, but notOct3/4 or c-Myc, also had a significant
effect on reducing colony formation frequencies compared
with OKMS alone. Thus, both KLF4 isoforms modulated
OKMS factor stoichiometry to subdue reprogramming
initiation.
In the late phase of reprogramming, we gauged stabiliza-
tion via mCherry silencing and Nanog-GFP activation (Fig-
ures 2E, 2F, and 2H). Supplementation of OKMSwith either
Klf4S or Klf4L was capable of activating Nanog-GFP with
co-incident repression of mCherry on d18. Interestingly,
although Sox2 supplementation also showed a repressive
effect on initiation, d18 mCherry+ and GFP+ proportions
remained mostly unchanged, indicating that additional
Sox2 fails to rescue the OKMS stabilization phase. Likewise,
Oct3/4 and c-Myc failed to promote Nanog-GFP reporter
activation or mCherry silencing. Thus, only Klf4 variants
were capable of augmenting the OKMS phenotype,
implying a sensitivity of reprogramming pathways to
KLF4 expression thresholds.
KLF4 Stoichiometry Is Reflected in Gene Expression
Analyses
Global gene expression has been used to define reprogram-
ming paths. In order to link gene expression to initial
reprogramming behaviors, we subjected d6 mCherry+ cells
from PB-TAC-OSKM, -OKMS, -OK+9MS, and -MKOS to
microarray analysis (Figures 3A and 3B). Based on OSKM
and OKMS GO term enrichment (data not shown) and
results from previous reports, we established sample index-
ing criteria (Figure 3A, left). Krt14 and Krt17 (encoding
structural proteins), as well as Sfn (a regulator of epithelial
cell growth), are claimed to activate in reprogramming
populations with preferred iPSC fate (O’Malley et al.,
2013). Expression of Ocln and Cdh1 indicates MET re-
sponses (Samavarchi-Tehrani et al., 2010), while additional
cell-surface changes are reflected by upregulation ofCadm1
and Fut9 (the fucosyltransferase responsible for producing
SSEA-1). The developmental regulators Tbx21 and Bcl11a
(transiently upregulated non-ESC markers; Polo et al.,
2012) and the pre-iPSC marker Nr0b1 (Mikkelsen et al.,Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The Authors 731
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2008) show the extent of reprogramming. As early as d6,
these ten marker genes were >2-fold differentially ex-
pressed between OK+9MS (green series) and OKMS (red se-
ries; Figure 3A, left), and <2-fold differentially expressed
in a pairwise correlation of OSKM to OK+9MS (R = 0.993;
Figure 3A, top right), certifying our indexing for further
pairwise comparisons. Correlation and indexing of OSKM
to OKMS verified the influence of KLF4 on early gene
expression responses (Figure 3A, bottom right).
GO term analysis of commonly upregulated gene ex-
pression versus mock-transfected MEFs (PB-TAC-lacZ)
was performed for cassettes containing Klf4L and Klf4S
(Figure 3B and data not shown). For Klf4S vectors (216
genes), only a few GO terms related to the biological
processes ‘‘regulation of cell adhesion (laminins)’’ and
‘‘tissue morphogenesis,’’ as well as the molecular func-
tion of ‘‘phospholipase C activity,’’ were enriched with
p values % 1.0E-3 (data not shown). Nearly double
the number of genes were activated by Klf4L constructs
(512 genes; Figure 3B; Table S1). The common gene set
for polycistronic Klf4L constructs significantly enriched
GO terms for cellular components of the ‘‘plasma mem-
brane’’ and ‘‘cell-cell junction’’ (consistent with an ex-
pected MET response), as well as distinct enrichment for
‘‘keratinocyte differentiation’’ and ‘‘epidermal cell differen-
tiation’’ biological processes (p = 2.3E-11 and 5.4E-11;
Figure 3B, right) with Benjamini scores = 3.6E-8 and
4.1E-8, respectively. These data are consistent with mono-
cistronic Klf4 expression (Figure S2B).
KLF4 Isoforms Divide Reprogramming Cassettes into
Two Major Classes
In order to more broadly understand the impact of KLF4-
mediated reprogramming outcomes, we extended ourFigure 2. KLF4 Stoichiometry Affects Reprogramming Phenotype
(A) Reprogramming with polycistronic OMS + monocistronic Klf4S or
mCherry or SSEA-1 on d8 (left) and mCherry versus Nanog-GFP on d18
(B) Western blot analysis of OCT3/4, SOX2, c-MYC, and KLF4 in OSKM
treatment. Actin was used as a loading control. Arrows show the two K
their positions relative to 2A peptides in the polycistronic cassette (
(C–F) Supplementation of PB-TAC-OKMS was performed by co-transfe
fusion gene.
(D) AP staining on d10 after transfection with OKMS alone or in combi
(E) Day 18 fluorescence microscopy of entire wells (composite 103 10
GFP+. Scale bars, 4,000 mm (full well) and 1,000 mm (inset).
(F) FACS analysis of mCherry and Nanog-GFP fractions in the d18 SSEA-
representative of the results of at least three independent experimen
(G) Quantification of the effects of factor supplementation on AP+ co
n.s., not significant. *p < 0.05, Student’s t test.
(H) Percentages of mCherry+ and Nanog-GFP+ populations from FA
independent experiments. n.s., not significant. *p < 0.05, Student’s
See also Figure S2.
Stemanalysis of publically available polycistronic constructs.
DNA sequence surveys revealed that Klf4S and Klf4L
reference cDNAs have been used interchangeably in the
reprogramming field (Table 1). To confirm that public
polycistronic vectors also display incongruous reprogram-
ming behaviors, we selected MKOS (Kaji et al., 2009),
STEMCCA (Sommer et al., 2009), EB-C5 (Chou et al.,
2011), and WTSI (Yusa et al., 2009), and applied our bat-
tery of phenotyping tests (Figure S3). mCherry+ fractions
and AP+ colony numbers varied among cassettes but
were highest for OKMS and EB-C5 (Figures S3A and
S3C). Notably, all four Klf4S cassettes (OKMS, STEMCCA,
EB-C5, and WTSI) showed large proportions of mCherry+
SSEA-1+ cells on d8 (>40%, compared with <21% for Klf4L
cassettes OSKM, OK+9MS, and MKOS; Figure S3B), a
characteristic that was consistently associated with Klf4S
(Figure 1H). In accordance with Klf4L construction and
western blotting data (Figure S2G), MKOS AP+ colony
numbers were low on d10, and became mostly GFP+
mCherry colonies on d18 (Figures S3D and S3E). On
the other hand, the Klf4S cassettes STEMCCA, EB-C5,
and WTSI all perpetuated mCherry expression after d8
passage (74.8%, 80.9%, and 79.6%, respectively), and acti-
vated Nanog-GFP in <3.0% of SSEA-1+ cells (Figure S3E).
Thus, the phenotypes elicited by these additional public
cassettes predictably correlated reprogramming hallmarks
with Klf4 coding length.
Finally, gene indexing confirmed that MKOS (Klf4L) is
distinct from STEMCCA (Klf4S; Figure 3C), substantiating
the phenotypes reported in Figure S3. Moreover, unsuper-
vised clustering of d6 mCherry+ cell gene expression pro-
files from all eight constructs (PB-TAC-OSKM, -OKMS,
-OK+9MS, -OKN-HAMS, -MKOS, -STEMCCA, -EB-C5, and
-WTSI) generated a dendogram (Figure 3D) that distinctlys
Klf4L leads to nearly identical phenotypes, as analyzed by FACS for
(right).
or OKMS transfected MEFs cultured for 2 days with or without dox
LF4 isoforms. Note that SOX2 and c-MYC also differ in size based on
Figure 1D). Uncropped data are provided in Figure S2G.
ction of additional factors in PB-TAB transposons. b-geo, lacZ-neo
nation with Oct3/4, Sox2, c-Myc, Klf4S, or Klf4L. Scale bar, 4,000 mm.
fields) or selected insets (33 3 subfields) for mCherry+ and Nanog-
1+ population of the cultures shown in (E). The results in (D)–(F) are
ts (summarized in G and H).
lony formation (D). Means ± SE for three independent experiments.
CS analysis of factor supplementation (F). Means ± SE for three
t test.
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Figure 3. Gene Expression Patterns
Reveal Klf4 Variants
(A) Pairwise comparison of global gene
expression in mCherry-positive cells on d6
from OSKM, OKMS, and OK+9MS reprogram-
ming. Diagonal lines indicate 2-fold
changes in log2 signal intensity. Genes
chosen for indexing are highlighted. Green:
Krt17, triangle; Sfn, circle; Ocln, square;
Cdh1, star; Krt14, inverted triangle. Red:
Fut9, triangle; Nr0b1, circle; Cadm1, square;
Tbx21, star; Bcl11a, inverted triangle.
(B) Left: Venn diagram showing overlapping
gene activation versus lacZ-MEFs in the
Klf4L cluster. Right: GO analysis of 512
shared d6 genes, arranged in order of p value
and indicating the proportion of genes
represented for each enriched GO term.
Cutoff p = 1.0E-3.
(C) Pairwise comparison of global gene
expression in mCherry-positive cells on d6
from MKOS and STEMCCA reprogramming.
Highlighted genes are those indicated in
(A).
(D) Dendogram resulting from unsupervised
clustering of OSKM, OKMS, OK+9MS, OKN-HA
MS, MKOS, STEMCCA, EB-C5, and WTSI
mCherry d6 array samples. Segregation of
the vectors based on the nature of the
KLF4 N terminus is indicated.
See also Figure S3 and Table S1.bifurcated based on the Klf4 variant employed in each vec-
tor (Table 1). Thus, early gene expression patterns disclosed
the nature of cloned Klf4. Intriguingly, despite unrelated
N-terminal sequence identity (yet predicted by pheno-
type), OKN-HAMS activated 463/512 (90%) of the core
Klf4L genes (data not shown) and clustered with Klf4L
vectors (Figure 3D). A standardized comparison of poly-
cistronic reprogramming cassettes thus implicates KLF4
isoforms in differential modulation of the reprogramming
transcriptome.734 Stem Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The AuthoDISCUSSION
Principally, we have uncovered a fundamental character-
istic of cloned Klf4 that governs relative factor stoichiom-
etry and reprogramming responses during mouse iPSC
derivation with polycistronic constructs. At the root of
our discovery lies the disparate coding prediction of full-
length Klf4 cDNA (Garrett-Sinha et al., 1996; Shields
et al., 1996), resulting in two proteins with distinct
N termini defined herein as KLF4S and KLF4L. These twors
Table 1. Survey of Publically Available Reprogramming Cassettes
Source Construct Data Forme Sequence Validation Publication
Distributiona
Addgene
Collectionb
Depositing
Scientist
Repository
ID Plasmid Name
Gene/Insert
Name Speciesc Typed Klf4S Klf4L AddGene
f Depositor Directg PMID Reference
Addgene stem cell;
Klf4/KLF4
Shinya
Yamanaka
13370 pMXs-Klf4 Kruppel-like
factor 4 (gut)
M. musculus mono C  B B 16904174 Takahashi and
Yamanaka,
2006
Addgene stem cell;
Klf4/KLF4
Shinya
Yamanaka
15920 pMXs-Klf4-IP Kruppel-like
factor 4 (gut)
M. musculus mono C  B B 16904174 Takahashi and
Yamanaka,
2006
Addgene Klf4/KLF4 Miguel
Ramalho-
Santos
15950 pLOVE-Klf4 Kruppel-like
factor 4
M. musculus mono n/d n/d n/c   18371358 Blelloch
et al., 2007
Addgene stem cell;
Klf4/KLF4
Shinya
Yamanaka
17219 pMXs-hKLF4 KLF4 H. sapiens mono C  B B 18035408 Takahashi
et al., 2007
Addgene stem cell;
Klf4/KLF4
George
Daley
17227 pMIG-hKLF4 Kruppel-like
factor 4 (gut)
H. sapiens mono C B   18157115 Park et al.,
2008
Addgene stem cell;
Klf4/KLF4
Kathrin Plath 17967 pMXs-hKLF4
(Plath)
Kruppel-like
factor 4 (gut)
H. sapiens mono C B B  18287077 Lowry et al.,
2008
Addgene stem cell;
Klf4/KLF4
Konrad
Hochedlinger
19764 pLV-tetO-Klf4 Klf4 M. musculus mono C n/c B  18371448 Stadtfeld
et al., 2008a
Addgene stem cell;
Klf4/KLF4
Konrad
Hochedlinger
19770 pAd-Klf4 Klf4 M. musculus mono C n/c B  18818365 Stadtfeld
et al., 2008b
Addgene stem cell;
Klf4/KLF4
Konrad
Hochedlinger
19777 FU-tet-o-hKLF4 KLF4 H. sapiens mono C n/c B  18786420 Maherali
et al., 2008
Addgene stem cell;
Klf4/KLF4
Juan
Belmonte
20074 pMSCV-Flag-hKlf4 hKlf4 H. sapiens mono C B   18931654 Aasen et al.,
2008
Addgene stem cell;
Klf4/KLF4
Rudolf
Jaenisch
20322 TetO-FUW-Klf4 Klf4 M. musculus mono C B B  18371436 Brambrink
et al., 2008
Addgene stem cell;
Klf4/KLF4
Rudolf
Jaenisch
20725 FUW-tetO-hKLF4 KLF4 H. sapiens mono C B B  18786421 Hockemeyer
et al., 2008
Addgene Klf4/KLF4 Rudolf
Jaenisch
20727 FUW-tetO-lox-
hKLF4
KLF4 H. sapiens mono C B B  19269371 Soldner
et al., 2009
Addgene Klf4/KLF4 Michel
Sadelain
23243 pLM-mCherry-
Klf4
mCherry_
2A_KLF4
H. sapiens mono C n/c B  19549847 Papapetrou
et al., 2009
(Continued on next page)
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Table 1. Continued
Source Construct Data Forme Sequence Validation Publication
Distributiona
Addgene
Collectionb
Depositing
Scientist
Repository
ID Plasmid Name
Gene/Insert
Name Speciesc Typed Klf4S Klf4L AddGene
f Depositor Directg PMID Reference
Addgene Klf4/KLF4 Rudolf
Jaenisch
26274 pBRPyCAG-fmKlf4-
DsRed-Ip
Klf4 M. musculus mono C n/c B  20442331 Hanna
et al., 2010
Addgene stem cell;
Klf4/KLF4
Derrick Rossi 26815 pcDNA3.3_KLF4 50UTR-KLF4-30UTR H. sapiens mono C B   20888316 Warren et al.,
2010
Addgene stem cell;
Klf4/KLF4
Steven Dowdy 36118 pCX4-KLF4 KLF4 H. sapiens mono n/d n/d n/c   22278060 Israel et al.,
2012
Addgene stem cell Rudolf
Jaenisch
20331 FUW-KO Klf4-F2A-Oct4 M. musculus bi C B B  19109433 Carey et al.,
2009
Addgene stem cell Rudolf
Jaenisch
20332 FUW-KM Klf4-F2A-cMyc M. musculus bi C B B  19109433 Carey et al.,
2009
Addgene stem cell James
Thomson
21164 pSIN4-CMV-K2M Klf4, cMyc H. sapiens bi C n/c B  19325077 Yu et al., 2009
Addgene stem cell Shinya
Yamanaka
27078 pCXLE-hSK SOX2, KLF4 H. sapiens bi C B B B 21460823 Okita et al.,
2011
Addgene stem cell;
Klf4/KLF4
Shinya
Yamanaka
41814 pCE-hSK SOX2, KLF4 H. sapiens bi C B B B 23193063 Okita et al.,
2013
Addgene Klf4/KLF4 Shinya
Yamanaka
19771 pCX-OKS-2A Oct3/4-2A-Klf4-
2A-Sox2
M. musculus poly C n/c B B 18845712 Okita et al.,
2008
Addgene stem cell;
Klf4/KLF4
Rudolf
Jaenisch
20321 TetO-FUW-OSKM Oct3/4-Sox2-Klf4-
cMyc
M. musculus poly C n/c B B 19109433 Carey et al.,
2009
Addgene stem cell;
Klf4/KLF4
Rudolf
Jaenisch
20325 FUW-SOKM Sox2-P2A-Oct4-
T2A-Klf4-E2A-
cMyc
M. musculus poly C n/c B  19109433 Carey et al.,
2009
Addgene stem cell;
Klf4/KLF4
Rudolf
Jaenisch
20327 FUW-SOK Sox2-F2A-Oct4-
T2A-Klf4
M. musculus poly C n/c B  19109433 Carey et al.,
2009
Addgene stem cell Rudolf
Jaenisch
20328 FUW-OSKM Oct4-P2A-Sox2-
T2A-Klf4-E2A-
cMyc
M. musculus poly C n/c B  19109433 Carey et al.,
2009
Addgene stem cell Keisuke Kaji 20865 pCAGMKOSiE c-Myc-F2A-Klf4-
T2A-Oct4-E2A-
Sox2 (Alt name)
M. musculus poly C B B B 19252477 Kaji et al.,
2009
(Continued on next page)
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Table 1. Continued
Source Construct Data Forme Sequence Validation Publication
Distributiona
Addgene
Collectionb
Depositing
Scientist
Repository
ID Plasmid Name
Gene/Insert
Name Speciesc Typed Klf4S Klf4L AddGene
f Depositor Directg PMID Reference
Addgene stem cell Keisuke Kaji 20866 pCAG2LMKOSimO c-Myc-F2A-Klf4-
T2A-Oct4-E2A-
Sox2-ires-
mOrange
M. musculus poly C B B B 19252477 Kaji et al.,
2009
Addgene stem cell;
Klf4/KLF4
James
Thomson
20923 pEP4 E02S EM2K Oct4 and Sox2;
Myc and Klf4
H. sapiens poly C n/c B  19325077 Yu et al., 2009
Addgene stem cell James
Thomson
20924 pEP4 E02S CK2M
EN2L
Oct4 and Sox2;
Nanog and Lin28;
Klf4 and Myc
H. sapiens poly C n/c B  19325077 Yu et al., 2009
Addgene stem cell James
Thomson
20925 pEP4 E02S EN2K Oct4 and Sox2;
Nanog and Klf4
H. sapiens poly C n/c B  19325077 Yu et al., 2009
Addgene stem cell;
Klf4/KLF4
James
Thomson
20927 pEP4 E02S ET2K Oct4 and Sox2;
SV40LT and Klf4
H. sapiens poly C n/c B  19325077 Yu et al., 2009
Addgene stem cell Tim Townes 21627 pKP332 (Lenti-
OSK1)
hOCT4 - 2A - hSOX2
- 2A - hKLF4
H. sapiens poly C B B  19415770 Chang et al.,
2009
Addgene stem cell;
Klf4/KLF4
Jose Cibelli 24603 OKSIM Oct4 KLF4
Sox2 c-Myc
H. sapiens poly C n/c B  20030562 Ross et al.,
2010
Addgene  Michel
Sadelain
27512 pLM-fSV2A OCT4_T2A_KLF4_
P2A_cMYC_
E2A_SOX2
H. sapiens poly C  B  21151124 Papapetrou
et al., 2011
Addgene stem cell Linzhao
Cheng
28213 pEB-C5 Oct4, Sox2, Klf4,
c-Myc, Lin28
M. musculus poly C B B  21243013 Chou et al.,
2011
Kotton Lab  Darrell
Kotton,
Gustavo
Mostoslavsky
 pHAGE-Tet-
STEMCCA
Oct3/4-Klf4-ires-
Sox2-cMyc
M. musculus poly C   B 19096035 Sommer
et al., 2009
WTSI  Alan
Bradley
 pPB-CAG.OSKM-
puDtk
O-T2A-S-T2A-
K-F2A-M
M. musculus poly C  B  19337237 Yusa et al.,
2009
RIKEN BRC  Knut
Woltjen
RDB13133 PB-TAC-OKMS Oct3/4-Klf4-
cMyc-Sox2
M. musculus poly C   B this study
RIKEN BRC  Knut
Woltjen
RDB13132 PB-TAC-OSKM Oct3/4-Sox2-
Klf4-cMyc
(from 20321)
M. musculus poly C   B this study
(Continued on next page)
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Table 1. Continued
Source Construct Data Forme Sequence Validation Publication
Distributiona
Addgene
Collectionb
Depositing
Scientist
Repository
ID Plasmid Name
Gene/Insert
Name Speciesc Typed Klf4S Klf4L AddGene
f Depositor Directg PMID Reference
RIKEN BRC  Knut
Woltjen
RDB13135 PB-TAC-OK+9MS Oct3/4-Klf4+9-
cMyc-Sox2
M. musculus poly C   B this study
RIKEN BRC  Knut
Woltjen
RDB13136 PB-TAC-STEMCCA Oct3/4-Klf4-ires-
Sox2-cMyc
(from Sommer
et al., 2009)
M. musculus poly C   B this study
RIKEN BRC  Knut
Woltjen
RDB13134 PB-TAC-MKOS c-Myc-F2A-Klf4-
T2A-Oct4-E2A-
Sox2 (from
20866)
M. musculus poly C   B this study
RIKEN BRC  Knut
Woltjen
RDB13137 PB-TAC-EB-C5 Oct4, Sox2,
Klf4, c-Myc,
Lin28 (from
28213)
M. musculus poly C   B this study
RIKEN BRC  Knut
Woltjen
RDB13138 PB-TAC-WTSI O-T2A-S-T2A-
K-F2A-M (from
Yusa et al., 2009)
M. musculus poly C   B this study
WTSI, Wellcome Trust Sanger Institute; RIKEN BRC, RIKEN Bio Resource Center DNA Bank. Closed circles indicate the Klf4 variant, and open circles denote sequence validation steps for each construct.
See also Figures 3 and S3.
aOnly vectors containing Klf4 are listed. Data from Addgene were current as of September 3, 2014. As Addgene is an independently curated and dynamically changing database, the authors do not
warrant the accuracy or completeness of this resource beyond the date of data collection.
bAddgene Collection lists can be found at http://www.addgene.org/stemcell/ and http://www.addgene.org/KLF/ or by browsing for Klf4 (gene 16600) or KLF4 (gene 9314).
cCompared to mouse Klf4L, the human ORF is 87% and 90% similar at the nucleotide and amino acid levels, respectively, with 100% conservation across the first 35 amino acids. The effect of human
Klf4S/L on reprogramming was not tested in this study.
d‘‘Type’’ refers to the number of cistrons or ORFs in the construct.
eComparison of the ATG start site with U70662.1 (Klf4S) and U20344.1 (Klf4L) reference cDNAs. Note that for polycistronic vectors, this annotation does not take into account elongation by 2A peptides.
n/d, form not determined by the available data.
fValidation of Klf4 identity was from Addgene sequencing data. n/c, no coverage of the Klf4 start site, although available sequence confirmed the presence of Klf4.
gCassette sequences were verified empirically by the authors.
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variants have seen unprejudiced use among vectors con-
structed for reprogramming (Table 1 and associated refer-
ences). OKMS (Klf4S) presented low KLF4 levels, which
were restored along with Klf4L-related phenotypes by elon-
gation of the KLF4S N terminus by 9aa. Thus, OK
+9MS
excluded the influence of 2A peptide choice and factor or-
der variation. Moreover, high KLF4-associated phenotypes
were reproduced by supplementation of OKMS with either
monocistronic Klf4S or Klf4L, limiting the effect to a poly-
cistronic context. Relative stoichiometry was explored in
a recent study, and it was found that chemically controlled
degradation of KLF4 resulted in premature termination of
reprogramming (Nishimura et al., 2014). Although precise
factor titration and more direct biochemical assays may be
required, our monocistronic reprogramming data argue
against modification of an N-terminal functional domain,
and rather support the idea that threshold levels of KLF4
are important for minimizing the occurrence of partial
reprogramming.
Polycistronic cassettes encoding KLF4S tend to permit
rapid expansion of transgenic cells with robust SSEA-1
activation. Yet, this majority population is ultimately
impeded in the acquisition and stabilization of pluripo-
tency, as indicated by transgene dependence and high-
level expression of markers associated with pre-iPSCs
(Mikkelsen et al., 2008; Theunissen et al., 2011). Polycis-
tronic reprogramming with Klf4L or OKMS supplementa-
tion with KlfS/L improved reporter activation and dox inde-
pendence. Nanog-GFP reporter activation is consistent
with a central role for KLF4 in the core ESC pluripotency
network, as ectopic expression of Klf4 promotes epiblast
stem cell conversion to ground-state pluripotency (Guo
et al., 2009) and prevents loss of pluripotency in the
absence of LIF (Niwa et al., 2009). Transgene silencing is
considered a hallmark of complete reprogramming (Goli-
pour et al., 2012). How the silencing phenomenon is
related to the acquisition of pluripotency, and whether
it is coordinated directly or indirectly through KLF4 are
issues of considerable interest.
Individual expression of either Klf4S or Klf4L in MEFs led
to a potent epidermal gene response (Figure S2B). More-
over, a similar response was noted as a common feature
of d6 reprogramming populations induced with Klf4L
cassettes (Figure 3B). A retrospective examination of early
reprogramming experiments recalls reports of epidermis-
related gene activation (Mikkelsen et al., 2008). Klf4
knockout mice die postnatally from failed epidermal
stratification (Segre et al., 1999). Reciprocally, ectopic Klf4
expression during embryogenesis results in premature bar-
rier formation (Jaubert et al., 2003). Therefore, it is perti-
nent that high KLF4 stoichiometry induces a cascade of
epithelialization and expression of epidermis-associated
genes such as Krt6a, Krt17, Sprr1a, Cnfn, and Tgm1 duringStemearly reprogramming (Figures 3A and 3B; Table S1). Inter-
estingly, many of these genes are not expressed in ESCs,
nor are they maintained in GFP+ iPSCs (data not shown),
which brings into question their relevance in iPSC
derivation. To address potential cellular heterogeneity, it
will be important to link gene expression responses and re-
programming outcomes to specific subpopulations of cells.
Thus, it remains to be determined whether the epidermal
response elicited by excess KLF4 in the early phase directly
contributes to high-fidelity reprogramming or to an alter-
nate cell fate.
On the path toward induced pluripotency, investigators
rely on gene expression patterns as milestones to gauge
appropriate progression, and comparative analysis of
publically available gene expression profiles is a common
approach. Clearly, our data show that inconsistencies
in the relative levels of KLF4 to OCT3/4, SOX2, and
c-MYC can fundamentally confound comparative anal-
ysis. Application of monocistronic Klf4S or Klf4L leads
to nearly indistinguishable reprogramming phenotypes.
Thus, typical clonal isolation of fully reprogrammed
iPSCs with monocistronic vectors, which is subject to
phenotypic selection for appropriate factor expression
levels, should be mostly unaffected. Mechanistic studies,
on the other hand, are prone to transcriptional noise
arising from variable factor expression between cells and
among transgenes. We expect the KLF4 threshold effects
observed herein to be pronounced when the relative
factor stoichiometry is fixed, for polycistronic transfec-
tion or even in secondary reprogramming systems with
pre-integrated transgenes (Wernig et al., 2008; Woltjen
et al., 2009). As such, we must be mindful that it is diffi-
cult to make direct comparisons across distinct reprog-
ramming systems without first defining the inherent
factor stoichiometry.EXPERIMENTAL PROCEDURES
Plasmid Construction
The PB transposon-based PB-TAC expression vector (RDB13131)
was generated by standard cloning (restriction digestion and liga-
tion). PB-TAB vectors containing the four Yamanaka factors were
generated by Gateway Cloning (Invitrogen) as described previ-
ously (Woltjen et al., 2009). Monocistronic and polycistronic re-
programming cassettes constructed in-house or obtained from
public resources (Table 1) were cloned into pDONR221 using
PCR and attB/P Clonase (Invitrogen) or pENTR2B using standard
restriction endonuclease cloning or InFusion (Takara Clontech).
Note that the cassette from pPB-CAG.OSKMBpuDtk (Yusa et al.,
2009) is in the order O-S-K-M, similarly to OSKM (Carey et al.,
2009), and thus is referred to in the text as WTSI to avoid confu-
sion. Modifications such as N-terminal extension and HA tagging
were produced using InFusion or the Q5 Site-Directed Mutagen-
esis Kit (New England Biolabs). Sequences of the main GatewayCell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The Authors 739
Entry constructs (from attL1 to attL2) were obtained using
Sanger sequencing with Big Dye Terminator Ver3.1 chemistry
(ABI) and assembled as contigs using Sequencher (GeneCodes).
Complete details regarding the cloning procedures used, includ-
ing InFusion amplification and sequencing primers, are available
upon request.MEF Isolation
Nanog-GFP (Okita et al., 2007) transgenic reporter mice were
maintained as homozygotes on a C57BL/6 background. For
ROSA-rtTA; Nanog-GFP double transgenic MEFs, C57BL/6 homo-
zygous ROSA26-rtTA females (Ohnishi et al., 2014) and inbred
homozygous Nanog-GFP males were crossed. Mice bearing
Col1a1-targeted OSKM and OKMS cassettes were generated as
described previously (Ohnishi et al., 2014). MEFs were isolated
from 12.5–13.5 days postcoitum transgenic embryos. Embryos
were decapitated, eviscerated, and macerated, and then dissoci-
ated with 0.25% trypsin/EDTA at 37C for 15 min and plated
in DMEM containing 10% fetal bovine serum (FBS), penicillin-
streptomycin, and L-glutamine. The presence of the desired
transgenes and male gender were determined by PCR genotyping
of residual embryonic tissues. Cells from male embryos were
expanded 1:5 once and then frozen in liquid nitrogen. Cells
for reprogramming were defrosted, counted, and plated for
transfection without additional expansion. The genotyping
primers are available upon request. Animal care and experiments
using animal tissues were approved by the CiRA Animal Ex-
periment Committee in accordance with Kyoto University
guidelines.PB Reprogramming and iPSC and ESC Culture
MEFs were seeded in DMEM containing 10% FBS, penicillin-strep-
tomycin, and L-glutamine on gelatinized (0.1%) 6-well dishes at
a density of 1.0 3 105 cells per 10 cm2. After a 24 hr culture, Fuge-
neHD (Promega) was used to transfect cells with 500 ng of transpo-
sons (PB-TAC-OSKM, -OKMS, -OK+9MS, -MKOS, -STEMCCA, -EB-
C5, -WTSI, -OKN-HAMS, -OK
+9
N-HAMS, and -lacZ) plus 1,000 ng
of pCyL43 PB transposase plasmid at a Fugene/DNA ratio of
8 mL:2 mg. For top-up experiments, cells were co-transfected with
500 ng of PB-TAC-OKMS along with 500 ng of PB-TAB-Oct3/4,
-Sox2, -c-Myc, -Klf4S, or -Klf4L, plus 1,000 ng of pCyL43 PB transpo-
sase plasmid. After 24 hr, the medium was replaced with ESC
medium (DMEM containing 15% FBS, penicillin-streptomycin,
GlutaMAX, b-mercaptoethanol, sodium-pyruvate, non-essential
amino acids, LIF, and dox [1 mg/mL]). After transfection, cells
were fed daily with dox-containing ESC medium. On d8, cells
were trypsinized and re-seeded at 3.0 3 105 cells per 10 cm2 on
gelatin for late-stage analysis (until d18). For dox withdrawal, cells
were again harvested on d18 and re-seeded at 3.0 3 105 cells per
10 cm2 on gelatin in the presence or absence of dox, and analyzed
on d24. For isolation of factor-independent iPSC clones, d18 cul-
tures were reseeded on gelatin at limiting dilutions in the absence
of dox, and colonies were picked on d24. Southern blot analysis
using HindIII digestion and an mCherry probe identified geneti-
cally unique iPSC lines. Both dox-independent iPSCs and ESCs
were maintained on mitomycin-c-inactivated DR4 MEF feeders
and gelatin in ESC medium, with passage every 2–3 days. For all740 Stem Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The Authocells, total viable cell counts were performed using a TC10 Auto-
mated Cell Counter (Bio-Rad) with trypan blue exclusion.
HEK293T Cell Culture and PB Transfection
HEK293T cells were maintained in DMEM containing 10% FBS,
penicillin-streptomycin, and L-glutamine. Then 3.0 3 105 cells
per 10 cm2 were transfected with 500 ng of transposons (PB-TAC-
OKN/C-HAMS and -OK
+9
N/C-HAMS) plus 500 ng of PB-CAG-rtTA
(Woltjen et al., 2009) at a Fugene/DNA ratio of 8 mL:2 mg. After
24 hr, the culture medium was replaced with medium containing
dox (1 mg/mL). After an additional 24 hr, transfected cells were
harvested for western blot analysis.
Whole-Well Fluorescence Microscopy Imaging
Mouse fibroblasts were plated on standard tissue culture 6-well
plastic plates (BD Falcon Labware). Images were acquired with a
Nikon BioStation CT (Nikon) equipped with GFP and mCherry
fluorescence filters and phase contrast using 23 lenses. The sin-
gle-plane images of each channel were stitched automatically us-
ing the automated image analysis software CL-Quant 3.0 (Nikon).
AP Staining
Staining for AP activity was performed using the BCIP/NBT
Alkaline Phosphatase Substrate Kit IV (SK-5400, Vector Labora-
tories) according to the manufacturer’s instructions. Images were
acquired with a color camera (Canon IXY Digital 900IS), and
colony count analysis was performed using a custom CL-Quant
3.0 macro developed in cooperation with Nikon, with AP-stained,
mock-transfected MEF plates used to establish background.
Flow Cytometry and Cell Sorting
For FACS analysis, 3.0 3 105 cells were stained on ice for 30 min
with Alexa Fluor 647 conjugated SSEA-1 (480, sc-21702, Santa
Cruz Biotechnology) antibody or the corresponding isotype-
matched control, mouse IgM (1:50 dilution). Control staining
with the appropriate isotype-matched control monoclonal anti-
bodies (BD Biosciences) was included to establish thresholds for
positive staining. Samples were analyzed using a BD LSRFortessa
Cell Analyzer (BD Biosciences) with BD FACSDiva software (BD
Biosciences). Flow cytometry data were analyzed and generated
by FlowJo software (Tree Star). For cell sorting, the mCherry+ cell
population was collected on a BD FACSAria II cell sorter (BD
Biosciences).
Microarray Analysis
Total RNA was prepared from harvested cells using the RNeasy
Mini Kit (QIAGEN) according to the manufacturer’s instructions.
cDNA synthesis and transcriptional amplification were performed
using 200 ng of total RNAwith theWhole Transcript (WT) Expres-
sion Kit (Ambion/Affymetrix). Fragmented and biotin-labeled
cDNA targets were hybridized to GeneChip Mouse Gene 1.0 ST
arrays (Affymetrix) according to the manufacturer’s protocols.
Hybridized arrays were scanned using an Affymetrix GeneChip
Scanner. Probe signal intensities were normalized with the RMA
algorithm inGeneSpring. Quality, correlation, and cluster analyses
were performed using GeneSpring GX software v12.1 (Agilentrs
Technologies). GO term analysis was performed using the NIH
DAVID Bioinformatics tool (http://david.abcc.ncifcrf.gov/). There
is no straightforward way to derive gene numbers directly from
probe sets, as the Affymetrix GeneChip Array platform makes
use of redundant probes for a small subset of genes. Moreover,
each expressed sequence tag (EST) is represented by a unique
probe, despite the fact that multiple ESTs may be associated
with a single gene transcript. For clarity, we refer to probe sets or
entities as ‘‘genes’’ in the text.
Protein Analysis
For western analysis, we prepared total cell lysates by boiling 1 3
106 cells for 10 min in SDS sample buffer (25 mM Tris (pH 6.8),
2% b-mercaptoethanol, 3% SDS, 0.05% bromophenol blue, and
5% glycerol). Lysates were resolved on SDS-polyacrylamide gels,
and proteins were detected by western blotting using ECL
Plus (Amersham Pharmacia). For western analysis, Sox-2 (Y-17,
sc-17320, 1:1,000) and GKLF (H-180, sc-20691, 1:500) antibodies
were used as described previously (Kaji et al., 2009). Mouse Anti-
Oct-3/4 (40/Oct-3, 611203, 1:1,000) and c-Myc (9402, 1:1,000)
antibodies were obtained from BD Biosciences and Cell Signaling,
respectively. HA-probe (F-7, sc-7392, 1:200) and anti-actin (A2066,
1:5,000) antibodies were obtained from Santa Cruz Biotechnology
and Sigma-Aldrich, respectively.
Material Distribution
The PB-TAC reprogramming transposons are available through the
RIKEN BRC DNA Bank (http://dna.brc.riken.jp) under accession
numbers RDB13131–RDB13138. Gateway versions of the polycis-
tronic reprogramming cassettes will be made available through
AddGene (http://www.addgene.org). The PB transposase vector
pCyL43 is available through the Wellcome Trust Sanger Center
(http://www.sanger.ac.uk/form/Sanger_CloneRequests).
ACCESSION NUMBERS
Datasets for the d6 gene expression microarray analysis have
been deposited in the Gene Expression Omnibus under accession
number GSE65468.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and one table and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2015.02.004.
AUTHOR CONTRIBUTIONS
K.W. conceived the study and wrote the manuscript with S.-I.K.
S.-I.K., F.O.-Y., and K.W. designed experiments. K.W. and R.H. per-
formed initial reprogramming trials, and S.-I.K. performed all sub-
sequent reprogramming experiments. K.W. designed and R.H.
generated and sequenced plasmid constructs. S.-I.K. collected
and analyzed FACS data. F.O.-Y. and S.-I.K. collected and analyzed
protein and imaging data. S.-I.K. and S.L. performed bioinformatic
analyses with advice from T.Y. K.O. and Y.Y. provided reporter cell
lines and mice. Y.Y. and S.Y. provided critical input on experi-
mental design and data analysis.StemACKNOWLEDGMENTS
We thank Kazutoshi Takahashi, Masamitsu Sone, and Ren Shima-
moto for their critical readings of the manuscript, and Katsunori
Semi for bioinformatics advice. We also thank Chiho Sakurai,
Michiko Nakamura, and Akiko Oishi for technical support; Tosh-
iko Sato for microarray preparations; Akito Tanaka for blastocyst
injections; and Kanako Asano and Kotaro Ohnishi for mouse hus-
bandry. We appreciate the advice of Hiroaki Kii (Nikon, Japan)
regarding image acquisition and analysis. We also thank Darrell
N. Kotton and Gustavo Mostoslavsky (Boston University School
of Medicine) for providing pHAGE-Tet-STEMCCA, Alan Bradley
and Kosuke Yusa (Wellcome Trust Sanger Institute) for providing
pPB-CAG.OSKMBpuDtk, Hitoshi Niwa (RIKENCenter for Develop-
mental Biology) for providing the pLefty1-luc reporter, and all
Addgene contributors, especially Linzhao Cheng and Rudolf
Jaenisch. This work was supported by the Cabinet Office, Govern-
ment of Japan and the Japan Society for the Promotion of Science
(JSPS) through the Funding Program forWorld-Leading Innovative
R&D on Science and Technology (FIRST Program), the Core Center
for iPS Cell Research, the Research Center Network for Realization
of Regenerative Medicine, and the Strategic International Collabo-
rative Research Program of the Japan Science and Technology
Agency (JST). K.W. is a Hakubi Center Special Project Researcher.
S.Y. is a non-salaried scientific advisor of iPS Academia Japan. S.L.
received funding from EPASI (JSPS/National Science Foundation,
2013). S.-I.K. is a JSPS Fellowship recipient (2011-2013) and JST
Researcher.
Received: August 8, 2014
Revised: February 6, 2015
Accepted: February 6, 2015
Published: March 12, 2015REFERENCES
Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonza-
lez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G., et al. (2008).
Efficient and rapid generation of induced pluripotent stem cells
from human keratinocytes. Nat. Biotechnol. 26, 1276–1284.
Blelloch, R., Venere, M., Yen, J., and Ramalho-Santos, M. (2007).
Generation of induced pluripotent stem cells in the absence of
drug selection. Cell Stem Cell 1, 245–247.
Brambrink, T., Foreman, R., Welstead, G.G., Lengner, C.J., Wernig,
M., Suh, H., and Jaenisch, R. (2008). Sequential expression of plu-
ripotency markers during direct reprogramming of mouse somatic
cells. Cell Stem Cell 2, 151–159.
Carey, B.W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitali-
pova, M., and Jaenisch, R. (2009). Reprogramming of murine
and human somatic cells using a single polycistronic vector.
Proc. Natl. Acad. Sci. USA 106, 157–162.
Carey, B.W., Markoulaki, S., Hanna, J.H., Faddah, D.A., Buganim,
Y., Kim, J., Ganz, K., Steine, E.J., Cassady, J.P., Creyghton, M.P.,
et al. (2011). Reprogramming factor stoichiometry influences the
epigenetic state and biological properties of induced pluripotent
stem cells. Cell Stem Cell 9, 588–598.Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The Authors 741
Chang, C.W., Lai, Y.S., Pawlik, K.M., Liu, K., Sun, C.W., Li, C.,
Schoeb, T.R., and Townes, T.M. (2009). Polycistronic lentiviral vec-
tor for ‘‘hit and run’’ reprogramming of adult skin fibroblasts to
induced pluripotent stem cells. Stem Cells 27, 1042–1049.
Chou, B.K., Mali, P., Huang, X., Ye, Z., Dowey, S.N., Resar, L.M.,
Zou, C., Zhang, Y.A., Tong, J., and Cheng, L. (2011). Efficient hu-
man iPS cell derivation by a non-integrating plasmid from blood
cells with unique epigenetic and gene expression signatures. Cell
Res. 21, 518–529.
David, L., and Polo, J.M. (2014). Phases of reprogramming. Stem
Cell Res. (Amst.) 12, 754–761.
Garrett-Sinha, L.A., Eberspaecher, H., Seldin, M.F., and de Crom-
brugghe, B. (1996). A gene for a novel zinc-finger protein expressed
in differentiated epithelial cells and transiently in certain mesen-
chymal cells. J. Biol. Chem. 271, 31384–31390.
Golipour, A., David, L., Liu, Y., Jayakumaran, G., Hirsch, C.L.,
Trcka, D., and Wrana, J.L. (2012). A late transition in somatic cell
reprogramming requires regulators distinct from the pluripotency
network. Cell Stem Cell 11, 769–782.
Graf, T. (2011). Historical origins of transdifferentiation and re-
programming. Cell Stem Cell 9, 504–516.
Guo, G., Yang, J., Nichols, J., Hall, J.S., Eyres, I., Mansfield, W., and
Smith, A. (2009). Klf4 reverts developmentally programmed re-
striction of ground state pluripotency. Development 136, 1063–
1069.
Hanna, J., Cheng, A.W., Saha, K., Kim, J., Lengner, C.J., Soldner, F.,
Cassady, J.P., Muffat, J., Carey, B.W., and Jaenisch, R. (2010).
Human embryonic stem cells with biological and epigenetic char-
acteristics similar to those ofmouse ESCs. Proc. Natl. Acad. Sci. USA
107, 9222–9227.
Hockemeyer, D., Soldner, F., Cook, E.G., Gao, Q., Mitalipova, M.,
and Jaenisch, R. (2008). A drug-inducible system for direct reprog-
ramming of human somatic cells to pluripotency. Cell StemCell 3,
346–353.
Israel, M.A., Yuan, S.H., Bardy, C., Reyna, S.M., Mu, Y., Herrera, C.,
Hefferan,M.P., VanGorp, S., Nazor, K.L., Boscolo, F.S., et al. (2012).
Probing sporadic and familial Alzheimer’s disease using induced
pluripotent stem cells. Nature 482, 216–220.
Jaubert, J., Cheng, J., and Segre, J.A. (2003). Ectopic expression of
kruppel like factor 4 (Klf4) accelerates formation of the epidermal
permeability barrier. Development 130, 2767–2777.
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., and
Woltjen, K. (2009). Virus-free induction of pluripotency and subse-
quent excision of reprogramming factors. Nature 458, 771–775.
Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J.,
Sridharan, R., Clark, A.T., and Plath, K. (2008). Generation of
human induced pluripotent stem cells from dermal fibroblasts.
Proc. Natl. Acad. Sci. USA 105, 2883–2888.
Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., and
Hochedlinger, K. (2008). A high-efficiency system for the genera-
tion and study of human induced pluripotent stem cells. Cell
Stem Cell 3, 340–345.
Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schor-
deret, P., Bernstein, B.E., Jaenisch, R., Lander, E.S., and Meissner,742 Stem Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The AuthoA. (2008). Dissecting direct reprogramming through integrative
genomic analysis. Nature 454, 49–55.
Nakatake, Y., Fukui, N., Iwamatsu, Y., Masui, S., Takahashi, K.,
Yagi, R., Yagi, K., Miyazaki, J., Matoba, R., Ko, M.S., and Niwa,
H. (2006). Klf4 cooperates with Oct3/4 and Sox2 to activate the
Lefty1 core promoter in embryonic stem cells. Mol. Cell. Biol.
26, 7772–7782.
Nishimura, K., Kato, T., Chen, C., Oinam, L., Shiomitsu, E., Aya-
kawa, D., Ohtaka, M., Fukuda, A., Nakanishi, M., and Hisatake,
K. (2014). Manipulation of KLF4 expression generates iPSCs
paused at successive stages of reprogramming. Stem Cell Reports
3, 915–929.
Niwa, H., Ogawa, K., Shimosato, D., and Adachi, K. (2009). A par-
allel circuit of LIF signalling pathways maintains pluripotency of
mouse ES cells. Nature 460, 118–122.
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mit-
sunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al.
(2014). Premature termination of reprogramming in vivo leads
to cancer development through altered epigenetic regulation.
Cell 156, 663–677.
Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of
germline-competent induced pluripotent stem cells. Nature 448,
313–317.
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., and Yama-
naka, S. (2008). Generation of mouse induced pluripotent stem
cells without viral vectors. Science 322, 949–953.
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Oka-
moto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., et al.
(2011). A more efficient method to generate integration-free
human iPS cells. Nat. Methods 8, 409–412.
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Wata-
nabe, A., Goshima, N., and Yamanaka, S. (2013). An efficient
nonviral method to generate integration-free human-induced
pluripotent stem cells from cord blood and peripheral blood cells.
Stem Cells 31, 458–466.
O’Malley, J., Skylaki, S., Iwabuchi, K.A., Chantzoura, E., Ruetz, T.,
Johnsson, A., Tomlinson, S.R., Linnarsson, S., and Kaji, K. (2013).
High-resolution analysis with novel cell-surface markers identifies
routes to iPS cells. Nature 499, 88–91.
Papapetrou, E.P., Tomishima, M.J., Chambers, S.M., Mica, Y.,
Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., and Sadelain,
M. (2009). Stoichiometric and temporal requirements of Oct4,
Sox2, Klf4, and c-Myc expression for efficient human iPSC induc-
tion and differentiation. Proc. Natl. Acad. Sci. USA 106, 12759–
12764.
Papapetrou, E.P., Lee, G., Malani, N., Setty, M., Riviere, I., Tiruna-
gari, L.M., Kadota, K., Roth, S.L., Giardina, P., Viale, A., et al.
(2011). Genomic safe harbors permit high beta-globin transgene
expression in thalassemia induced pluripotent stem cells. Nat. Bio-
technol. 29, 73–78.
Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A.,
Lerou, P.H., Lensch, M.W., and Daley, G.Q. (2008). Reprogram-
ming of human somatic cells to pluripotency with defined factors.
Nature 451, 141–146.rs
Plath, K., and Lowry, W.E. (2011). Progress in understanding
reprogramming to the induced pluripotent state. Nat. Rev. Genet.
12, 253–265.
Polo, J.M., Anderssen, E., Walsh, R.M., Schwarz, B.A., Nefzger,
C.M., Lim, S.M., Borkent, M., Apostolou, E., Alaei, S., Cloutier, J.,
et al. (2012). Amolecular roadmap of reprogramming somatic cells
into iPS cells. Cell 151, 1617–1632.
Ross, P.J., Suhr, S.T., Rodriguez, R.M., Chang, E.A., Wang, K., Siri-
pattarapravat, K., Ko, T., and Cibelli, J.B. (2010). Human-induced
pluripotent stem cells produced under xeno-free conditions.
Stem Cells Dev. 19, 1221–1229.
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.K., Beyer,
T.A., Datti, A., Woltjen, K., Nagy, A., and Wrana, J.L. (2010). Func-
tional genomics reveals a BMP-driven mesenchymal-to-epithelial
transition in the initiation of somatic cell reprogramming. Cell
Stem Cell 7, 64–77.
Segre, J.A., Bauer, C., and Fuchs, E. (1999). Klf4 is a transcription
factor required for establishing the barrier function of the skin.
Nat. Genet. 22, 356–360.
Shields, J.M., Christy, R.J., and Yang, V.W. (1996). Identification
and characterization of a gene encoding a gut-enriched Kru¨ppel-
like factor expressed during growth arrest. J. Biol. Chem. 271,
20009–20017.
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook,
E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al.
(2009). Parkinson’s disease patient-derived induced pluripotent
stem cells free of viral reprogramming factors. Cell 136, 964–977.
Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K.,
Kotton, D.N., and Mostoslavsky, G. (2009). Induced pluripotent
stem cell generation using a single lentiviral stem cell cassette.
Stem Cells 27, 543–549.
Stadtfeld, M., Maherali, N., Breault, D.T., and Hochedlinger, K.
(2008a). Defining molecular cornerstones during fibroblast to
iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240.
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hochedlinger, K.
(2008b). Induced pluripotent stem cells generated without viral
integration. Science 322, 945–949.StemTakahashi, K., and Yamanaka, S. (2006). Induction of pluripotent
stem cells from mouse embryonic and adult fibroblast cultures
by defined factors. Cell 126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T.,
Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent
stem cells from adult human fibroblasts by defined factors. Cell
131, 861–872.
Theunissen, T.W., and Jaenisch, R. (2014). Molecular control of
induced pluripotency. Cell Stem Cell 14, 720–734.
Theunissen, T.W., van Oosten, A.L., Castelo-Branco, G., Hall, J.,
Smith, A., and Silva, J.C. (2011). Nanog overcomes reprogramming
barriers and induces pluripotency in minimal conditions. Curr.
Biol. 21, 65–71.
Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina,
W., Mandal, P.K., Smith, Z.D., Meissner, A., et al. (2010). Highly
efficient reprogramming to pluripotency and directed differentia-
tion of human cells with synthetic modified mRNA. Cell Stem
Cell 7, 618–630.
Wernig, M., Lengner, C.J., Hanna, J., Lodato, M.A., Steine, E.,
Foreman, R., Staerk, J., Markoulaki, S., and Jaenisch, R. (2008).
A drug-inducible transgenic system for direct reprogramming of
multiple somatic cell types. Nat. Biotechnol. 26, 916–924.
Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M.,
Ha¨ma¨la¨inen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M.,
et al. (2009). piggyBac transposition reprograms fibroblasts to
induced pluripotent stem cells. Nature 458, 766–770.
Yamaguchi, S., Hirano, K., Nagata, S., and Tada, T. (2011). Sox2
expression effects on direct reprogramming efficiency as deter-
mined by alternative somatic cell fate. Stem Cell Res. (Amst.) 6,
177–186.
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and
Thomson, J.A. (2009). Human induced pluripotent stem cells free
of vector and transgene sequences. Science 324, 797–801.
Yusa, K., Rad, R., Takeda, J., and Bradley, A. (2009). Generation of
transgene-free induced pluripotent mouse stem cells by the piggy-
Bac transposon. Nat. Methods 6, 363–369.Cell Reports j Vol. 4 j 727–743 j April 14, 2015 j ª2015 The Authors 743
